Domestic Airline Travel

Domestic Airline Travel Antitrust Litigation consolidates claims that major U.S. airlines coordinated on capacity discipline — deliberately limiting the growth of available seats — to keep domestic airfares higher than a competitive market would produce. Centralized in the District of Columbia in 2015, the docket carries 105 pending actions a decade later, one of the larger active populations among the antitrust MDLs on the JPML's current report, reflecting both the size of the affected purchaser class (essentially any ticket purchaser during the relevant period) and a claim population that has continued generating individual and follow-on actions well after the docket's core liability record was developed.

For a funder, a capacity-discipline theory is economically distinct from a conventional price-fixing conspiracy: it requires proving coordinated output restriction through circumstantial evidence — earnings-call statements, industry-conference conduct, and capacity-growth data — rather than direct evidence of an explicit price agreement. That evidentiary structure has been extensively litigated in this docket over a decade, which narrows liability uncertainty for new entrants to the claim pool, but damages modeling still requires purchaser-specific fare and travel-volume data.

That profile supports portfolio finance for corporate travel departments, travel management companies, or law firms holding a book of institutional ticket-purchaser claims with documented travel spend during the relevant period. Criterica Capital's commercial litigation finance line is the applicable product, with claim value scaling in a reasonably predictable way against verified travel volume. A structure and litigation brief on the current claim population and underlying capacity-discipline theory is also available.

Pre-settlement funding is a non-recourse purchase of a portion of the proceeds of a pending legal claim — not a loan. If the case does not result in a recovery, nothing is owed. Rates, fees, and repayment terms are disclosed in full in the funding agreement, which the applicant’s attorney reviews before signing. Availability and terms vary by state.